Cargando…

Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort

INTRODUCTION: The gut microbiota (GM) dysbiosis is one of the causal factors for the progression of different chronic metabolic diseases, including type 2 diabetes mellitus (T2D). Understanding the basis that laid this association may lead to developing new therapeutic strategies for preventing and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neri-Rosario, Daniel, Martínez-López, Yoscelina Estrella, Esquivel-Hernández, Diego A., Sánchez-Castañeda, Jean Paul, Padron-Manrique, Cristian, Vázquez-Jiménez, Aarón, Giron-Villalobos, David, Resendis-Antonio, Osbaldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333697/ https://www.ncbi.nlm.nih.gov/pubmed/37441494 http://dx.doi.org/10.3389/fendo.2023.1170459

Ejemplares similares

A network perspective on the ecology of gut microbiota and progression of type 2 diabetes: Linkages to keystone taxa in a Mexican cohort
por: Esquivel-Hernández, Diego A., et al.
Publicado: (2023)

Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era
por: Martínez-López, Yoscelina Estrella, et al.
Publicado: (2022)

Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort
por: Diener, Christian, et al.
Publicado: (2021)

MICOM: Metagenome-Scale Modeling To Infer Metabolic Interactions in the Gut Microbiota
por: Diener, Christian, et al.
Publicado: (2020)

On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers
por: Vázquez-Jiménez, Aarón, et al.
Publicado: (2021)

Dysbiosis of gut microbiota and decreased propionic acid associated with metabolic abnormality in Cushing’s syndrome
por: Zhang, Qin, et al.
Publicado: (2023)

Filling Kinetic Gaps: Dynamic Modeling of Metabolism Where Detailed Kinetic Information Is Lacking
por: Resendis-Antonio, Osbaldo
Publicado: (2009)

Endometriosis and dysbiosis: State of art
por: Zizolfi, Brunella, et al.
Publicado: (2023)

Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies
por: Diener, Christian, et al.
Publicado: (2016)

Editorial: Systems Biology and the Challenge of Deciphering the Metabolic Mechanisms Underlying Cancer
por: Resendis-Antonio, Osbaldo, et al.
Publicado: (2017)

Boolean modeling reveals that cyclic attractors in macrophage polarization serve as reservoirs of states to balance external perturbations from the tumor microenvironment
por: de León, Ugo Avila-Ponce, et al.
Publicado: (2022)

Uncoding the interdependency of tumor microenvironment and macrophage polarization: insights from a continuous network approach
por: Avila-Ponce de León, Ugo, et al.
Publicado: (2023)

Gut microbiota signature of pathogen-dependent dysbiosis in viral gastroenteritis
por: Mizutani, Taketoshi, et al.
Publicado: (2021)

Editorial: Neuroendocrine signalling pathways along the microbiota-gut-brain axis in functional gut disorders
por: Giron, Maria Cecilia, et al.
Publicado: (2022)

Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect
por: Resendis-Antonio, Osbaldo, et al.
Publicado: (2010)

Transcriptional and Microenvironmental Landscape of Macrophage Transition in Cancer: A Boolean Analysis
por: Avila-Ponce de León, Ugo, et al.
Publicado: (2021)

Randomized Clinical Trial: Probiotics Alleviated Oral-Gut Microbiota Dysbiosis and Thyroid Hormone Withdrawal-Related Complications in Thyroid Cancer Patients Before Radioiodine Therapy Following Thyroidectomy
por: Lin, Baiqiang, et al.
Publicado: (2022)

Macrophage Boolean networks in the time of SARS-CoV-2
por: de León, Ugo Avila-Ponce, et al.
Publicado: (2022)

Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity
por: Burmeister, Melissa A., et al.
Publicado: (2023)

Editorial: Dysbiosis, obesity, and inflammation: interrelated phenomena causes or effects of metabolic syndrome?
por: Wani, Kaiser, et al.
Publicado: (2023)

MicroRNAs Regulate Metabolic Phenotypes During Multicellular Tumor Spheroids Progression
por: Muciño-Olmos, Erick Andrés, et al.
Publicado: (2020)

Functional Modules, Structural Topology, and Optimal Activity in Metabolic Networks
por: Resendis-Antonio, Osbaldo, et al.
Publicado: (2012)

“Gestaltomics”: Systems Biology Schemes for the Study of Neuropsychiatric Diseases
por: Gutierrez Najera, Nora A., et al.
Publicado: (2017)

Gut microbial dysbiosis in patients with Cushing’s disease in long-term remission. Relationship with cardiometabolic risk
por: Valassi, Elena, et al.
Publicado: (2023)

Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis
por: Liu, Changan, et al.
Publicado: (2022)

Systems biology of cancer: moving toward the integrative study of the metabolic alterations in cancer cells
por: Hernández Patiño, Claudia E., et al.
Publicado: (2013)

The space of enzyme regulation in HeLa cells can be inferred from its intracellular metabolome
por: Diener, Christian, et al.
Publicado: (2016)

Analysis of Epithelial-Mesenchymal Transition Metabolism Identifies Possible Cancer Biomarkers Useful in Diverse Genetic Backgrounds
por: Matadamas-Guzman, Meztli, et al.
Publicado: (2020)

Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome
por: Martinez, Jason E., et al.
Publicado: (2021)

Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?
por: Faucher, Quentin, et al.
Publicado: (2022)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Fungal microbiota dysbiosis in IBD
por: Sokol, Harry, et al.
Publicado: (2017)

Microbiota Dysbiosis in Fungal Rhinosinusitis
por: Lu, Yen-Ting, et al.
Publicado: (2019)

Total Astragalus saponins can reverse type 2 diabetes mellitus-related intestinal dysbiosis and hepatic insulin resistance in vivo
por: Ma, Leilei, et al.
Publicado: (2023)

Taxonomic and Functional Fecal Microbiota Signatures Associated With Insulin Resistance in Non-Diabetic Subjects With Overweight/Obesity Within the Frame of the PREDIMED-Plus Study
por: Atzeni, Alessandro, et al.
Publicado: (2022)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Microbiota dysbiosis in hereditary angioedema patients
por: Özdemir, Öner
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7v9o8ovg3u1c4ugrtinkgrntg